Cargando…

Evaluation of candidate vaccine approaches for MERS-CoV

The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) as a cause of severe respiratory disease highlights the need for effective approaches to CoV vaccine development. Efforts focused solely on the receptor-binding domain (RBD) of the viral Spike (S) glycoprotein may not optimize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lingshu, Shi, Wei, Joyce, M. Gordon, Modjarrad, Kayvon, Zhang, Yi, Leung, Kwanyee, Lees, Christopher R., Zhou, Tongqing, Yassine, Hadi M., Kanekiyo, Masaru, Yang, Zhi-yong, Chen, Xuejun, Becker, Michelle M., Freeman, Megan, Vogel, Leatrice, Johnson, Joshua C., Olinger, Gene, Todd, John P., Bagci, Ulas, Solomon, Jeffrey, Mollura, Daniel J., Hensley, Lisa, Jahrling, Peter, Denison, Mark R., Rao, Srinivas S., Subbarao, Kanta, Kwong, Peter D., Mascola, John R., Kong, Wing-Pui, Graham, Barney S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525294/ https://www.ncbi.nlm.nih.gov/pubmed/26218507 http://dx.doi.org/10.1038/ncomms8712

Ejemplares similares

MERS-CoV vaccine candidates in development: The current landscape
por: Modjarrad, Kayvon
Publicado: (2016)

3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012
por: Johnson, Reed F., et al.
Publicado: (2016)

Lack of Effect of Lamivudine on Ebola Virus Replication
por: Hensley, Lisa E., et al.
Publicado: (2015)

Animal models for SARS and MERS coronaviruses
por: Gretebeck, Lisa M, et al.
Publicado: (2015)

Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
por: Houser, Katherine V., et al.
Publicado: (2016)

Automated computer quantification of breast cancer in small-animal models using PET-guided MR image co-segmentation
por: Bagci, Ulas, et al.
Publicado: (2013)

A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation
por: Modjarrad, Kayvon, et al.
Publicado: (2016)

Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD
por: Wang, Nianshuang, et al.
Publicado: (2019)

Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
por: Sutton, Troy C., et al.
Publicado: (2015)

Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses
por: Chuang, Gwo-Yu, et al.
Publicado: (2021)

Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
por: Houser, Katherine V., et al.
Publicado: (2017)

Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies
por: Dyall, Julie, et al.
Publicado: (2017)

Predicting Future Morphological Changes of Lesions from Radiotracer Uptake in 18F-FDG-PET Images
por: Bagci, Ulas, et al.
Publicado: (2013)

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
por: Bisht, Himani, et al.
Publicado: (2005)

Treatment strategies for Middle East respiratory syndrome coronavirus
por: Modjarrad, Kayvon
Publicado: (2016)

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
por: Kapadia, Sagar U., et al.
Publicado: (2005)

MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells
por: Cong, Yu, et al.
Publicado: (2018)

Multiple co-circulating HIV-1 subtypes in the Middle East and North Africa
por: Rolland, Morgane, et al.
Publicado: (2015)

Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease
por: Johnson, Reed F., et al.
Publicado: (2015)

High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona
por: Honko, Anna N., et al.
Publicado: (2017)

Ensuring HIV Data Availability, Transparency and Integrity in the MENA Region: Comment on "Improving the Quality and Quantity of HIV Data in the Middle East and North Africa: Key Challenges and Ways Forward"
por: Modjarrad, Kayvon, et al.
Publicado: (2017)

Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?
por: Modjarrad, Kayvon, et al.
Publicado: (2020)

Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
por: Ying, Tianlei, et al.
Publicado: (2015)

Molecular Imaging of Influenza and Other Emerging Respiratory Viral Infections
por: Bray, Mike, et al.
Publicado: (2011)

Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks
por: Joyce, M. Gordon, et al.
Publicado: (2020)

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
por: Bukreyev, Alexander, et al.
Publicado: (2004)

A computational pipeline for quantification of pulmonary infections in small animal models using serial PET-CT imaging
por: Bagci, Ulas, et al.
Publicado: (2013)

EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination
por: Krug, Peter W., et al.
Publicado: (2023)

Automatic Detection and Quantification of Tree-in-Bud (TIB) Opacities from CT Scans
por: Bagci, Ulas, et al.
Publicado: (2012)

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
por: Dussupt, Vincent, et al.
Publicado: (2021)

Potential Vaccines and Post-Exposure Treatments for Filovirus Infections
por: Friedrich, Brian M., et al.
Publicado: (2012)

Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
por: Vogel, Leatrice N., et al.
Publicado: (2007)

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015
por: Modjarrad, Kayvon, et al.
Publicado: (2016)

The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses
por: Paules, Catharine I, et al.
Publicado: (2017)

CD26/DPP4 Cell-Surface Expression in Bat Cells Correlates with Bat Cell Susceptibility to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Evolution of Persistent Infection
por: Caì, Yíngyún, et al.
Publicado: (2014)

Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529
por: Zhou, Tongqing, et al.
Publicado: (2022)

Quantitative Image Quality Comparison of Reduced- and Standard-Dose Dual-Energy Multiphase Chest, Abdomen, and Pelvis CT
por: Buty, Mario, et al.
Publicado: (2017)

Toward Developing a Preventive MERS-CoV Vaccine—Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14–15, 2015
por: Excler, Jean-Louis, et al.
Publicado: (2016)

The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis)
por: Zaucha, Gary M, et al.
Publicado: (2001)

Animal models and vaccines for SARS-CoV infection
por: Roberts, Anjeanette, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rag01ellufg2vh7i7apsncv7el